Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report.
Indian J Ophthalmol
; 69(10): 2865-2866, 2021 10.
Article
in English
| MEDLINE | ID: covidwho-1441265
ABSTRACT
A central retinal vein occlusion (CRVO) case in a patient developed with sudden blurred vision in some hemifield areas of his left eye, maintaining 20/20 vision 15-days after the COVID-19 vaccination. Initial retinal findings were venous dilation and tortuosity with dispersing dot hemorrhages. Fluorescein angiography (FA) and optical coherence tomography (OCT) confirmed a non-ischemic CRVO diagnosis, and a complete blood panel was requested with average results. An intravitreal steroid dose was applied. A decrease in best-corrected visual acuity (BCVA) (20/30) with more intraretinal hemorrhages was documented. An intravitreal dose of bevacizumab and oral apixaban were added with a final BCVA of 20/20 with decreased hemorrhages. There is no specific causal relationship between COVID-19 vaccines and CRVO. Without previous risk factors and positive treatment response, this case may correlate the first COVID-19 vaccine dose and the event.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Retinal Vein Occlusion
/
Macular Edema
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Indian J Ophthalmol
Year:
2021
Document Type:
Article
Affiliation country:
Ijo.IJO_1477_21
Similar
MEDLINE
...
LILACS
LIS